Tonix Pharmaceuticals initiates Phase 2 fibromyalgia trial

|About: Tonix Pharmaceuticals Holdi... (TNXP)|By:, SA News Editor

Tonix Pharmaceuticals (TNXP) starts a Phase 2b trial for its lead product candidate, the fibromyalgia treatment TNX-102.

Primary endpoint: Change in pain intensity.

Top-line results due in H2 2014. (PR)